The Latest Breaking News from MHRA

Obese and overweight adults could have access to Tirzepatide – also known as Mounjaro – if it receives further approval.

Exclusive: Regulator extends part suspension of licence to July 2024 after IT blunder led to incorrect dosage of cancer treatment

Last week, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) had released a report stating that "there have been some suspected reports of new-onset or aggravation of pre-existing myasthenia gravis or ocular myasthenia associated with statin use." Myasthenia gravis is an autoimmune neuromuscular disorder that is characterised by fluctuating…

Vorasidenib worked in trials but is not yet available on the NHS

The condition is caused after the repeated use of steroid creams and tablets commonly prescribed by the NHS, Holly Evans writes

NHS is first health system to offer injection to hundreds of patients which will cut treatment times by up to three quarters

The Information Commissioner’s Office urged organisations to ensure their performance and processes complied with the law.

Hospital admissions for life-threatening allergic reactions have increased from 12,361 in 2002-03 to 25,721 in the past year, latest NHS figures show.

Ron Huss-Smickler, 41 from Birmingham, and Steven Lawrence Beckford, 39 from Edgbaston, bought the non-certified coronavirus tests from Alibaba.